KUKJEON PHARMACEUTICAL Ratios and Metrics

Market cap in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Feb '26 Feb 18, 2026	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Market Capitalization	158,056	172,478	306,192	324,839	537,308
Market Cap Growth	-14.79%	-43.67%	-5.74%	-39.54%	-
Enterprise Value	178,823	178,557	319,290	284,635	-
Last Close Price	3150.00	3515.00	6222.17	6590.26	10900.81
PE Ratio	-	99.34	63.47	36.30	133.06
PS Ratio	1.19	1.26	2.51	3.13	6.30
PB Ratio	1.61	1.77	3.14	3.52	6.46
P/TBV Ratio	1.62	1.80	3.22	3.60	6.50
P/FCF Ratio	957.50	79.52	-	-	-
P/OCF Ratio	47.31	17.19	-	-	176.63
EV/Sales Ratio	1.34	1.31	2.62	2.75	-
EV/EBITDA Ratio	257.78	32.63	33.11	57.72	-
EV/EBIT Ratio	-	486.92	49.05	81.60	-
EV/FCF Ratio	1083.31	82.32	-	-	-
Debt / Equity Ratio	0.45	0.67	0.81	0.64	0.09
Debt / EBITDA Ratio	52.77	11.94	8.17	12.03	1.09
Debt / FCF Ratio	270.47	30.11	-	-	-
Net Debt / Equity Ratio	0.21	0.19	0.14	-0.39	-0.38
Net Debt / EBITDA Ratio	24.92	3.38	1.45	-7.22	-4.35
Net Debt / FCF Ratio	127.69	8.52	-0.31	1.22	4.26
Asset Turnover	0.65	0.62	0.58	0.68	-
Inventory Turnover	5.07	4.22	4.05	4.62	-
Quick Ratio	0.78	0.85	0.94	1.67	2.72
Current Ratio	1.16	1.19	1.24	2.02	3.52
Return on Equity (ROE)	-4.38%	0.55%	4.95%	10.12%	-
Return on Assets (ROA)	-1.33%	0.10%	1.93%	1.44%	-
Return on Invested Capital (ROIC)	-3.59%	0.20%	7.75%	5.15%	9.38%
Return on Capital Employed (ROCE)	-3.80%	0.30%	5.20%	2.80%	7.20%
Earnings Yield	-2.29%	1.01%	1.58%	2.76%	0.75%
FCF Yield	0.10%	1.26%	-14.46%	-9.02%	-1.37%
Dividend Yield	0.32%	0.28%	-	-	-
Payout Ratio	-	28.26%	-	5.48%	-
Buyback Yield / Dilution	-2.04%	-	4.23%	-16.16%	-
Total Shareholder Return	-1.73%	0.28%	4.23%	-16.16%	-

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.